(Q54509252)

30 May 2018

title

Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease. (English)

1 reference

30 May 2018

1 reference

Markus Klemke

1

1 reference

30 May 2018

Anke Meyer

2

1 reference

30 May 2018

Maliheh Hashemi Nezhad

3

1 reference

30 May 2018

Sabine Bartnitzke

4

1 reference

30 May 2018

Norbert Drieschner

5

1 reference

30 May 2018

Christiane Frantzen

6

1 reference

30 May 2018

Ernst Heinrich Schmidt

7

1 reference

30 May 2018

Gazanfer Belge

8

1 reference

30 May 2018

Jörn Bullerdiek

9

1 reference

30 May 2018

publication date

1 February 2009

1 reference

30 May 2018

Genes, Chromosomes and Cancer

published in

1 reference

30 May 2018

volume

48

1 reference

30 May 2018

issue

2

1 reference

30 May 2018

page(s)

171-178

1 reference

30 May 2018

Fusion of a sequence from HEI10 (14q11) to the HMGIC gene at 12q15 in a uterine leiomyoma.

cites work

1 reference

Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2

21 January 2018

1 reference

Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains

21 January 2018

1 reference

7 January 2021

High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence

1 reference

7 January 2021

Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias

1 reference

7 January 2021

The frequency of uterine leiomyomas

1 reference

7 January 2021

Roles of HMGA proteins in cancer

1 reference

7 January 2021

HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies

1 reference

7 January 2021

Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene

1 reference

7 January 2021

Benign gynecological tumors: estimated incidence. Results of the German Cohort Study on Women's Health

1 reference

7 January 2021

Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps

1 reference

7 January 2021

Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells

1 reference

7 January 2021

Expression of proliferative and preapoptotic molecules in human myometrium and leiomyoma throughout the menstrual cycle

1 reference

7 January 2021

Rapid subchromosomal localization of cosmids by nonradioactive in situ hybridization

1 reference

7 January 2021

Suppression of non-small cell lung tumor development by the let-7 microRNA family

1 reference

7 January 2021

Novel gene fusion of COX6C at 8q22-23 to HMGIC at 12q15 in a uterine leiomyoma

1 reference

7 January 2021

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

1 reference

7 January 2021

DNA architectural factor and proto-oncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells

1 reference

7 January 2021

High-level expression of DNA architectural factor HMGA2 and its association with nucleosomes in human embryonic stem cells

1 reference

7 January 2021

Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata

1 reference

7 January 2021

Variation in the Incidence of Uterine Leiomyoma Among Premenopausal Women by Age and Race

1 reference

7 January 2021

Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation

1 reference

7 January 2021

Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family

1 reference

7 January 2021

Uterine leiomyoma cytogenetics

1 reference

7 January 2021

Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma

1 reference

7 January 2021

Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours

1 reference

7 January 2021

Let-7 expression defines two differentiation stages of cancer

1 reference

7 January 2021

1 reference

7 January 2021

Evidence for RAD51L1/HMGIC fusion in the pathogenesis of uterine leiomyoma

1 reference

7 January 2021

HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes

1 reference

7 January 2021

Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase

1 reference

7 January 2021

Is HMGIC rearranged due to cryptic paracentric inversion of 12q in karyotypically normal uterine leiomyomas?

1 reference

7 January 2021

Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma.

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20627

1 reference

30 May 2018

1 reference

30 May 2018